[go: up one dir, main page]

FR2424027A1 - Nouveau medicament, notamment sedatif et inducteur de sommeil et compositions pharmaceutiques la renfermant - Google Patents

Nouveau medicament, notamment sedatif et inducteur de sommeil et compositions pharmaceutiques la renfermant

Info

Publication number
FR2424027A1
FR2424027A1 FR7812711A FR7812711A FR2424027A1 FR 2424027 A1 FR2424027 A1 FR 2424027A1 FR 7812711 A FR7812711 A FR 7812711A FR 7812711 A FR7812711 A FR 7812711A FR 2424027 A1 FR2424027 A1 FR 2424027A1
Authority
FR
France
Prior art keywords
medicinal product
pharmaceutical compositions
compositions containing
sleep inducer
new medicinal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7812711A
Other languages
English (en)
Other versions
FR2424027B1 (fr
Inventor
Pierre Fonlupt
Maurice Roche
Lucien Cronenberger
Henri Pacheco
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut Merieux SA
Original Assignee
Institut Merieux SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut Merieux SA filed Critical Institut Merieux SA
Priority to FR7812711A priority Critical patent/FR2424027A1/fr
Priority to JP5075879A priority patent/JPS54145222A/ja
Priority to CH394879A priority patent/CH640137A5/fr
Priority to DE2916880A priority patent/DE2916880C2/de
Priority to NL7903307A priority patent/NL7903307A/xx
Priority to IT22168/79A priority patent/IT1202914B/it
Priority to LU81199A priority patent/LU81199A1/fr
Priority to BE0/194901A priority patent/BE875932A/fr
Priority to GB7914876A priority patent/GB2019720B/en
Publication of FR2424027A1 publication Critical patent/FR2424027A1/fr
Application granted granted Critical
Publication of FR2424027B1 publication Critical patent/FR2424027B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurosurgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

NOUVEAU MEDICAMENT. CE MEDICAMENT EST CARACTERISE PAR LE FAIT QU'IL CONTIENT LA S-ADENOSYL-L-HOMOCYSTEINE (SAH) OU UN DE SES SELS PHARMACEUTIQUEMENT ACCEPTABLES. APPLICATION NOTAMMENT COMME SEDATIF ET INDUCTEUR DU SOMMEIL.
FR7812711A 1978-04-28 1978-04-28 Nouveau medicament, notamment sedatif et inducteur de sommeil et compositions pharmaceutiques la renfermant Granted FR2424027A1 (fr)

Priority Applications (9)

Application Number Priority Date Filing Date Title
FR7812711A FR2424027A1 (fr) 1978-04-28 1978-04-28 Nouveau medicament, notamment sedatif et inducteur de sommeil et compositions pharmaceutiques la renfermant
JP5075879A JPS54145222A (en) 1978-04-28 1979-04-24 Novel medicine * especially anodyne and sleep inducer and medical composition
DE2916880A DE2916880C2 (de) 1978-04-28 1979-04-26 Arzneimittel mit sedativer und schlafinduzierender Wirkung
NL7903307A NL7903307A (nl) 1978-04-28 1979-04-26 Geneesmiddel, in het bijzonder sedativum en slaap op- wekkend middel en farmaceutische preparaten.
CH394879A CH640137A5 (fr) 1978-04-28 1979-04-26 Composition pharmaceutique contenant de la s-adenosyl-l-homocysteine.
IT22168/79A IT1202914B (it) 1978-04-28 1979-04-26 Composto a base di s-adenosil-l-omocisteina avente attivita' farmaceutica quale sedativo e induttore di sonno e composizioni farmaceutiche contenenti il medesimo
LU81199A LU81199A1 (fr) 1978-04-28 1979-04-27 Nouveau medicament,notamment sedatif et inducteur de sommeil et compositions pharmaceutiques le renfermant
BE0/194901A BE875932A (fr) 1978-04-28 1979-04-27 Nouveau medicament, notamment sedatif et inducteur de sommeil et compositions pharmaceutiques le renfermant
GB7914876A GB2019720B (en) 1978-04-28 1979-04-30 Adenosyl-l-homocysteine and salts thereof for use in therapy

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7812711A FR2424027A1 (fr) 1978-04-28 1978-04-28 Nouveau medicament, notamment sedatif et inducteur de sommeil et compositions pharmaceutiques la renfermant

Publications (2)

Publication Number Publication Date
FR2424027A1 true FR2424027A1 (fr) 1979-11-23
FR2424027B1 FR2424027B1 (fr) 1981-05-08

Family

ID=9207735

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7812711A Granted FR2424027A1 (fr) 1978-04-28 1978-04-28 Nouveau medicament, notamment sedatif et inducteur de sommeil et compositions pharmaceutiques la renfermant

Country Status (9)

Country Link
JP (1) JPS54145222A (fr)
BE (1) BE875932A (fr)
CH (1) CH640137A5 (fr)
DE (1) DE2916880C2 (fr)
FR (1) FR2424027A1 (fr)
GB (1) GB2019720B (fr)
IT (1) IT1202914B (fr)
LU (1) LU81199A1 (fr)
NL (1) NL7903307A (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1193529B (it) * 1980-04-22 1988-07-08 Bioresearch Srl Derivati adenosinici ad attivita' antinfiammatoria ed analgesica e composizioni terapeutiche che li contengono come principio attivo
US9925583B2 (en) 2013-07-11 2018-03-27 Crucible Intellectual Property, Llc Manifold collar for distributing fluid through a cold crucible
JP2021046375A (ja) * 2019-09-19 2021-03-25 ポッカサッポロフード＆ビバレッジ株式会社 β３アドレナリン受容体活性化剤

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2313937A1 (fr) * 1975-06-09 1977-01-07 Anvar Medicament a base de 5' thioethers de l'adenosine

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2313937A1 (fr) * 1975-06-09 1977-01-07 Anvar Medicament a base de 5' thioethers de l'adenosine

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
NV2054X/75 *

Also Published As

Publication number Publication date
DE2916880A1 (de) 1979-11-15
GB2019720A (en) 1979-11-07
GB2019720B (en) 1982-09-02
BE875932A (fr) 1979-08-16
IT7922168A0 (it) 1979-04-26
IT1202914B (it) 1989-02-15
NL7903307A (nl) 1979-10-30
DE2916880C2 (de) 1982-12-09
JPS6212205B2 (fr) 1987-03-17
CH640137A5 (fr) 1983-12-30
LU81199A1 (fr) 1979-10-30
JPS54145222A (en) 1979-11-13
FR2424027B1 (fr) 1981-05-08

Similar Documents

Publication Publication Date Title
FR2429593A1 (fr) Medicaments contenant des derives d'imidazole
NO920740D0 (no) Doseringsform for oral administrering av hypoglykemisk glipizid
IE862404L (en) Hydroxamic acid derivatives
DE58901002D1 (de) Mittel mit zerstoerender wirkung auf maligne tumore, verfahren zu dessen herstellung und praeparation zur anwendung in der therapie von krebskranken.
ES460098A1 (es) Metodo para producir derivados de acido penicilanico.
IT1256697B (it) Medicamenti per trattare condizioni infiammatorie o per analgesia.
IT1170214B (it) Composizione farmaceutica per la cura delle arteriopatie periferiche
FR2438654A1 (fr) Compose de 2-methyl-dihydropyridine, procedes pour son obtention et composition pharmaceutique contenant ce compose
FR2457689A1 (fr) Medicament hypolipemique a base de carnitine
FR2439194A1 (fr) Derives de la dibenzothiepine, leur procede de preparation et leur application therapeutique
FR2429019A1 (fr) Medicaments contenant des esters de 1-b-d-arabinofuranosylcytosine-5'-phosphate
FR2424027A1 (fr) Nouveau medicament, notamment sedatif et inducteur de sommeil et compositions pharmaceutiques la renfermant
DE3764111D1 (de) Arzneimittelkombination.
FR2387230A1 (fr) Nouvelles pyrroloquinoxalines et leurs sels, procede de preparation et application a titre de medicaments
ES8707111A1 (es) Procedimiento para obtencion de un preparado farmaceutico para tratamiento terapeutico de enfermedades reumaticas.
FR2355502A1 (fr) Application a titre de medicaments d'un derive de la piperazine et de ses sels
FR2367067A1 (fr) Nouveaux derives de la piperazine et medicaments contenant ces substances
ATE204474T1 (de) Amethocain enthaltende arzneimittel
ZA939153B (en) Use of idazoxan and its derivatives for the preparation of a medicinal product intended for the treatment of parkinson's disease and its development
BE1003067A5 (fr) Derives de la pyrimidine.
ATE91890T1 (de) Herstellung eines arzneimittels gegen arthritis und rheumatismus.
GB1362400A (en) 1-amino-isoquinoline derivatives
Earle et al. Studies on the chemotherapy of the human malarias. X. The suppressive antimalarial effect of paludrine
GB1141702A (en) Therapeutic compositions
FR2387035A1 (fr) Nouveau medicament destine notamment au traitement des troubles fonctionnels cerebraux

Legal Events

Date Code Title Description
ST Notification of lapse